TROPHIMMUN: Avelumab for gestational trophoblastic tumours resistant to monochemotherapy

KEYNOTE-177 results: Pembrolizumab versus chemotherapy for patients with MSI-H/dMMR colorectal cancer

Highlights from ASCO 2020

PARP inhibitors in prostate cancer: Guidelines, who to test and the patient pathway

Conducting Oncology Clinical Trials in Africa II: ACTC Informational Session

Timing of response to venetoclax combination treatment in older patients with acute myeloid leukaemia

CheckMate 227 three-year update: Nivolumab plus ipilimumab versus chemo as first-line treatment for advanced NSCLC

Conducting Oncology Clinical Trials in Africa II: Practical steps for conducting clinical trials in Africa

ASCO 2020: Latest developments in EGFR-mutated non-small cell lung cancer

Ensuring quality care for breast cancer patients globally

Venetoclax with bortezomib and dexamethasone in relapsed/refractory multiple myeloma

KRd vs VRd for initial therapy of newly diagnosed multiple myeloma